- Report
- November 2023
- 149 Pages
Global
From €2417EUR$2,499USD£2,047GBP
- Report
- November 2023
- 146 Pages
Global
From €2417EUR$2,499USD£2,047GBP
- Report
- October 2023
- 147 Pages
Global
From €2417EUR$2,499USD£2,047GBP
- Report
- May 2023
- 144 Pages
Global
From €2417EUR$2,499USD£2,047GBP
- Report
- January 2024
- 150 Pages
Global
From €4690EUR$4,850USD£3,972GBP
- Report
- January 2024
- 150 Pages
Global
From €4690EUR$4,850USD£3,972GBP
- Report
- May 2023
- 150 Pages
Global
From €4690EUR$4,850USD£3,972GBP
- Report
- February 2024
- 178 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- February 2024
- 182 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- February 2024
- 187 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- November 2023
- 178 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- November 2023
- 180 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- November 2023
- 190 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- November 2023
- 190 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- October 2023
- 181 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- October 2023
- 190 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- October 2023
- 190 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- October 2023
- 182 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- October 2023
- 175 Pages
Global
From €4739EUR$4,900USD£4,013GBP
- Report
- June 2023
- 112 Pages
Global
From €4739EUR$4,900USD£4,013GBP
The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more